News

Don't ignore those symptoms. Head and neck cancers are far more manageable, and often curable, with less aggressive treatment ...
Dr Hisham Mehanna, an expert in cancer at the University of Birmingham, said seven in 10 throat cancers are believed to be ...
Parents and guardians in Wales are being encouraged to protect young people against HPV related cancers by ensuring they take up the offer of the HPV vaccine in school ...
Laryngeal cancer is a serious condition that can impact your ability to speak, swallow and in some cases, breathe. Each year, ...
First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and ...
As part of the initiative, mirrors will be placed in hospital waiting areas to encourage visitors to perform self-checks.
Early stage diagnosis offers the most favorable prognosis for cancer treatment. Although conventional screening methods ...
A new treatment delivery for Head and Neck Cancer Dr. Geraldine LunaConsultant, Asian Cancer Institute | Asian Hospital and Medical CenterCancer comes in ...
BioAtla Inc (BCAB) showcases significant advancements in clinical trials while navigating financial hurdles and seeking strategic partnerships.
Phase 1 dose-escalation study ongoing, dosed first three patients at 300 micrograms; data readout expected mid-2025 with dose expansion data readout anticipated 1H 2026Mecbotamab vedotin (Mec-V; ...
A recent study published in Engineering has shed new light on the mechanisms underlying the metastasis of head and neck squamous cell carcinoma (HNSCC).
Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...